Wealthspire Advisors (New York)’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$218K Sell
4,002
-681
-15% -$33.2K ﹤0.01% 1140
2026
Q1
$201K Sell
4,683
-1,525
-25% -$65.6K ﹤0.01% 871
2025
Q4
$272K Buy
6,208
+1,458
+31% +$60.3K ﹤0.01% 848
2025
Q3
$196K Sell
4,750
-260
-5% -$10.4K ﹤0.01% 801
2025
Q2
$221K Buy
+5,010
New +$200K ﹤0.01% 756

Other funds holding EXEL

Wealthspire Advisors (New York)'s EXEL Position: Q2 2026 in Review

Wealthspire Advisors (New York) reduced its Exelixis (EXEL) stake by 15% in Q2 2026, selling an estimated $33.2K and leaving 4,002 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #1140.

Wealthspire Advisors (New York) first reported a position in EXEL in Q2 2025 and has held it in 5 quarters since. The position peaked at $272K in Q4 2025. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Wealthspire Advisors (New York) held 4,002 shares of Exelixis worth $218K as of Q2 2026.
  • Wealthspire Advisors (New York) sold 681 Exelixis shares in Q2 2026, an estimated $33.2K.
  • Exelixis made up ﹤0.01% of Wealthspire Advisors (New York)'s portfolio in Q2 2026, its #1140 holding.
  • Wealthspire Advisors (New York) first reported a position in Exelixis in Q2 2025 and has held it in 5 quarters since.
  • Wealthspire Advisors (New York)'s Exelixis position peaked at $272K in Q4 2025.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q2 2026, filed 11 Aug 2026.